The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index; none of the 7 sources its claims cite is checked for support yet.
FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
Open accessAbstract
Hypoxia-inducible factor 1 (HIF-1) is a master regulator of oxygen homeostasis that controls angiogenesis, erythropoiesis, and glycolysis via transcriptional activation of target genes under hypoxic conditions. O 2 -dependent binding of the von Hippel-Lindau (VHL) tumor suppressor protein targets the HIF-1α subunit for ubiquitination and proteasomal degradation. The activity of the HIF-1α transactivation domains is also O 2 regulated by a previously undefined mechanism. Here, we report the identification of factor inhibiting HIF-1 (FIH-1), a protein that binds to HIF-1α and inhibits its transactivation function. In addition, we demonstrate that FIH-1 binds to VHL and that VHL also functions as a transcriptional corepressor that inhibits HIF-1α transactivation function by recruiting histone deacetylases. Involvement of VHL in association with FIH-1 provides a unifying mechanism for the modulation of HIF-1α protein stabilization and transcriptional activation in response to changes in cellular O 2 concentration.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
The paper identifies FIH-1, a 349-amino-acid protein that binds HIF-1α and VHL and represses HIF-1 transcriptional activity. It proposes that VHL and FIH-1 act as corepressors by recruiting histone deacetylases, unifying O₂-dependent control of HIF-1α stability and transactivation.
Key findings
- A yeast two-hybrid screen of 2 × 10⁶ transformants identified FIH-1 from a 2.98-kb human brain cDNA encoding a 349-amino-acid protein; the FIH1 gene maps to chromosome 10q24 and consists of eight exons and seven introns spanning 14 kb.
- FIH-1 binds HIF-1α residues 531–826, with optimal binding requiring TAD-C; residues 757–826 are sufficient, whereas TAD-N (531–575) and TAD-C alone (786–826) did not bind.
- FIH-1 inhibits HIF-1α transactivation in 293 and Hep3B reporter assays at 1% O₂; antisense FIH-1 increases reporter expression, and FIH-1 inhibits GalA (HIF-1α 531–826) under both 20% and 1% O₂.
- FIH-1 binds VHL at a distinct site (VHL residues 1–155 sufficient for FIH-1 binding; 1–213 required for efficient HIF-1α binding), and VHL plus FIH-1 cooperatively repress GalL (HIF-1α 531–575); VHL binds HDAC-1, HDAC-2, and HDAC-3 and recruits HDACs to HIF-1α.
Methods
- Yeast two-hybrid assay using GAL4 DBD–HIF-1α(576–826) bait and a human brain cDNA prey library; 2 × 10⁶ transformants screened for histidine auxotrophy and α-galactosidase expression.
- In vitro GST pull-down assays with ³⁵S-labeled HIF-1α, FIH-1, VHL, and HDAC proteins; some GST-HIF-1α fusions were preincubated with reticulocyte lysate to induce proline hydroxylation.
- Transient transfection of HEK293 and Hep3B cells with p2.1 or pG5ElbLuc reporters and GAL4–HIF-1α fusion constructs, exposed to 20% or 1% O₂; immunoprecipitation and immunoblot assays for protein interactions.
Limitations
- Stated: coimmunoprecipitation of FIH-1 and HIF-1α was detected in cells overexpressing these proteins, so no conclusion can be drawn as to whether the interaction is regulated by cellular O₂ concentration; VHL expression may have been limiting, and no interaction of VHL with FIH-1 or HIF-1α could be demonstrated under those conditions.
- Stated: whether O₂-dependent interaction of HIF-1α and VHL is required for recruitment of FIH-1 remains unanswered; an alternative but not mutually exclusive hypothesis is that FIH-1 and VHL recruit distinct HDAC complexes.
- Evident: many interaction and repression conclusions rely on overexpression and in vitro binding assays; FIH-1’s weaker HDAC binding and the possibilities that it interacts with HDAC-4–7, another corepressor, or possesses intrinsic HDAC activity are speculative and not demonstrated.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 7 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction of VHL and FIH-1 with histone deacetylases.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Functional interaction of FIH-1 and VHL to repress HIF-1␣ transactivation domain function.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Effect of FIH-1 on HIF-1-mediated reporter gene transcription.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction of FIH-1, HIF-1␣, and VHL in vitro.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Identification of FIH-1 by yeast two-hybrid screen.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: The physical interaction of bait and prey proteins within yeast cells functionally reconstitutes an active GAL4 transcription factor, resulting in expression of genes containing upstream GAL4-binding sites that mediate histidine auxotrophy and α-gal expression.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction of FIH-1 and HIF-1␣ in human cells.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Localization of HIF-1␣ residues interacting with FIH-1.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“binding of VHL to the intact HIF-1␣ regulatory domain (residues 531-826) does not require preincubation of HIF-1␣ with cellular lysate (as a source of putative prolyl hydroxylase activity; Fig. 4D)”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“TBLASTN searches revealed similarity of FIH-1 to the rat PASS1 protein (GenBank accession no.AF168362.1),proteins encoded by human ESTs FLJ13798 (AK023860.1)and FLJ20656 (AK000663.1),as well as to open reading frames in Caenorhabditis briggsae (AC084551.1)and Drosophila melanogaster (AE003469.2,AE003537.2) genomic DNA, thus defining a family of related proteins that has been conserved through inve”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Identification of FIH-1 in a screen for HIF-1␣-interacting proteins
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Thus, FIH-1 loss-of-function may contribute to increased HIF-1-mediated transactivation of downstream target genes such as VEGF in gliomas and other human cancers (Semenza 2000; Zagzag et al. 2000).”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Discussion
What the sources say
- Not checked yetcites Semenza 2000
- Not checked yetcites Zagzag et al. 2000
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 4
- Probably not a substantial claim. 3
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Nucleotide sequence analysis revealed that the prey vector contained a 2.98-kb human cDNA encoding a 349-amino-acid protein that was subsequently designated FIH-1 (GenBank accession no.AF395830).”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Identification of FIH-1 in a screen for HIF-1␣-interacting proteins
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Analysis of genomic DNA sequences deposited in Gen-Bank revealed that the FIH1 gene is present in contig NT 008635, which is mapped to human chromosome 10q24, and consists of eight exons and seven introns that span 14 kb of DNA.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Identification of FIH-1 in a screen for HIF-1␣-interacting proteins
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither FIH-1 nor VHL alone inhibited GalL-mediated transactivation, whereas the combination of FIH-1 and VHL resulted in significant transcriptional repression.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Inhibition of HIF-1␣ transactivation domain function by VHL and FIH-1 in human cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“EST data indicate that FIH-1 is expressed in multiple cell types derived from adrenal, bladder, brain (adult and fetal), breast, colon, embryo, foreskin, germ cell, heart, kidney, lung, lymph, marrow, muscle, nerve, ovary, parathyroid, prostate, skin, testis, tonsil, and uterus.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Identification of FIH-1 in a screen for HIF-1␣-interacting proteins
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Negative regulation of HIF-1␣ protein stability and transcriptional activity under nonhypoxic conditions mediated by VHL and FIH-1.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: Elongins B and C and cullin 2 are required for E3 ubiquitin-protein ligase activity, whereas HDACs repress transactivation.
In the paper
“Residues 576-785 comprise an inhibitory domain the deletion of which increases transactivation domain function especially under nonhypoxic conditions (Jiang et al. 1997).”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Abstract
What the sources say
- Not checked yetcites Jiang et al. 1997
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
HIF-1 activity is induced by hypoxia in all cell types.
“Because HIF-1 activity is induced by hypoxia in all cell types, the interaction of HIF-1 with other proteins is likely to play a major role in determining its biological activity.”
The paper relies on this without support.
HIF-1α contains basic helix-loop-helix (bHLH) and PAS domains required for dimerization and DNA binding, a proline/serine/threonine-rich protein stabilization domain (PSTD), two transactivation domains (TAD-N and TAD-C), and an inhibitory domain (ID) that negatively regulates transactivation domain function under nonhypoxic conditions.
“HIF-1␣ contains basic helix-loop-helix (bHLH) and PAS domains that are required for dimerization and DNA binding, a proline/serine/threonine-rich protein stabilization domain (PSTD), two transactivation domains (TAD-N and TAD-C), and an inhibitory domain (ID) that negatively regulates transactivation domain function under nonhypoxic conditions.”
The paper relies on this without support.
Elongins B and C and cullin 2 are required for E3 ubiquitin-protein ligase activity, whereas HDACs repress transactivation.
“Elongins B and C and cullin 2 are required for E3 ubiquitin-protein ligase activity, whereas HDACs repress transactivation.”
The paper relies on this without support.
The physical interaction of bait and prey proteins within yeast cells functionally reconstitutes an active GAL4 transcription factor, resulting in expression of genes containing upstream GAL4-binding sites that mediate histidine auxotrophy and α-gal expression.
“The physical interaction of the bait and prey proteins within yeast cells functionally reconstitutes an active GAL4 transcription factor, resulting in the expression of genes that contain upstream GAL4-binding sites and mediate histidine auxotrophy (his + ) and ␣-gal expression.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“although it remains capable of binding the CAD under these conditions (Mahon et al. 2001).”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Mahon et al. 2001
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HIF transcriptional activity is also regulated by a second oxygen-sensitive hydroxylation event mediated by factor inhibiting HIF-1 (FIH-1) (Mahon et al., 2001;Lando et al., 2002).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Mahon et al., 2001
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This mechanism attenuates HIF transcriptional activity during early reoxygenation, acting as a buffer that limits the excessive metabolic activation and oxidative stress during the transition from hypoxia to normoxia”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“FIH-1 functions at lower oxygen tensions than PHDs and hydroxylates a single asparagine residue within the C-terminal transactivation domain of HIF-1α, consequently limiting engagement of transcriptional co-activator complexes [52,53]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although the two modes of regulation can be apparently uncoupled from each other through the construction of chimeras containing either the ODD or the CAD, the machinery regulating the two appears to be linked (Mahon et al. 2001).”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Mahon et al. 2001
The cited source says what the claim attributes to it.
In the citing paper
“In vitro binding studies suggest that FIH-1 and pVHL interact and may be part of a larger complex that represses HIF by multiple mechanisms under normoxic conditions (Mahon et al. 2001)”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Mahon et al. 2001
In the citing paper
“Hif-1α is also hydroxylated in an oxygen-dependent reaction on a highly conserved asparagine residue by FIH-1 (Factor inhibiting HIF-1), which blocks the ability of Hif-1α to recruit transcriptional coactivators such as p300/CBP, in turn limiting transcriptional activation by Hif-1α under non-hypoxic conditions [45, 46].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [45]
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Self-citationA novel genetic system to detect protein–protein interactions
Fields, S., & Song, O.-K. (1989) · Nature · doi:10.1038/340245a0 · Cited by 6,152
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Hoffman, C. S., & Winston, F. (1987) · Gene · doi:10.1016/0378-1119(87)90131-4 · Cited by 2,492
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Self-citationHuang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Purification and Characterization of Hypoxia-inducible Factor 1
Wang, G. L., & Semenza, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1230 · Cited by 2,094
Self-citation
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,002
Novel Function of Orphan Nuclear Receptor Nur77 in Stabilizing Hypoxia-inducible Factor-1α
Yoo, Y., Yeo, M. G., Kim, D. K., Park, H., & Lee, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408554200 · Cited by 58
MicroRNA‐135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth
Aakula, A., Leivonen, S., Hintsanen, P., Aittokallio, T. A., Ceder, Y., Børresen‐Dale, A., Perälä, M., Östling, P., & Kallioniemi, O. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.03.001 · Cited by 57
Hypoxia-regulated gene network in drug resistance and cancer progression
Lin, S.-C., Liao, W.-L., Lee, J., & Tsai, S. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214532755 · Cited by 58
Aprelikova, O. N., Pandolfi, S., Tackett, S. A., Ferreira, M., Salnikow, K., Ward, Y., Risinger, J. I., Barrett, J. C., & Niederhuber, J. E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0811 · Cited by 62
Chen, T., Zhou, Q., Tang, H., Bozkanat, K. M., Yuan, J. X. ‐., Raj, J. U., & Zhou, G. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004510 · Cited by 58
Hypoxia and Chromatin: A Focus on Transcriptional Repression Mechanisms
Batie, M., del Peso, L., & Rocha, S. (2018) · Biomedicines · doi:10.3390/biomedicines6020047 · Cited by 61
Rani, S., Roy, S., Singh, M., & Kaithwas, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2407223 · Cited by 57
Nishida, C., Kusubata, K., Tashiro, Y., Gritli, I., Sato, A., Ohki, M., Morita, Y., Nagano, M., Sakamoto, T., Koshikawa, N., et al. (2012) · Blood · doi:10.1182/blood-2011-11-390849 · Cited by 56
The effects of 2-hydroxyglutarate on the tumorigenesis of gliomas
Reiter–Brennan, C., Semmler, L., & Klein, A. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.82642 · Cited by 57
Dioxygenases as O2-dependent regulators of the hypoxic response pathway
Dann, C. E., & Bruick, R. K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.140 · Cited by 56
Action Sites and Clinical Application of HIF-1α Inhibitors
Xu, R., Wang, F., Yang, H., & Wang, Z. (2022) · Molecules · doi:10.3390/molecules27113426 · Cited by 59
LY6E: a conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis
Yeom, C. J., Zeng, L., Gotö, Y., Morinibu, A., Zhu, Y., Shinomiya, K., Kobayashi, M., Itasaka, S., Yoshimura, M., Hur, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11670 · Cited by 55
microRNA-184 Induces a Commitment Switch to Epidermal Differentiation
Nagosa, S., Leesch, F., Putin, D., Bhattacharya, S., Altshuler, A., Serror, L., Amitai-Lange, A., Nasser, W., Aberdam, É., Rouleau, M., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.10.030 · Cited by 55
The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin
Masson, N., Appelhoff, R. J., Tuckerman, J. R., Tian, Y., Demol, H., Puype, M., Vandekerckhove, J. S., Ratcliffe, P. J., & Pugh, C. W. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.040 · Cited by 55
Hypoxic Signaling in Skeletal Muscle Maintenance and Regeneration: A Systematic Review
Pircher, T., Wackerhage, H., Aszódi, A., Kammerlander, C., Böcker, W., & Saller, M. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.684899 · Cited by 57
Hypoxia and HIFs in regulating the development of the hematopoietic system
Imanirad, P., & Dzierzak, E. A. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.08.005 · Cited by 54
Dale, E. A., Satriotomo, I., & Mitchell, G. S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3873-11.2012 · Cited by 54
Lindholm, M. E., Fischer, H., Poellinger, L., Johnson, R. S., Gustafsson, T. P., Sundberg, C. J., & Rundqvist, H. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00036.2013 · Cited by 54
Fandrey, J., Schödel, J., Eckardt, K., Katschinski, D. M., & Wenger, R. H. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02334-8 · Cited by 54
Ikeda, H., & Kakeya, H. (2021) · The Journal of Antibiotics · doi:10.1038/s41429-021-00451-0 · Cited by 60
Kastner, D. W., Nandy, A., Mehmood, R., & Kulik, H. J. (2023) · ACS Catalysis · doi:10.1021/acscatal.2c06241 · Cited by 53
Hypoxia in aquatic invertebrates: Occurrence and phenotypic and molecular responses
Lee, Y., Byeon, E., Kim, D., Maszczyk, P., Wang, M., Wu, R. S. S., Jeung, H.-D., Hwang, U.-K., & Lee, J. (2023) · Aquatic Toxicology · doi:10.1016/j.aquatox.2023.106685 · Cited by 53
The role of the miR-31 /FIH1 pathway in TGF-β-induced liver fibrosis
Hu, J., Chen, C., Liu, Q., Liu, B., Song, C., Zhu, S., Wu, C., Liu, S., Yu, H., Yao, D., et al. (2015) · Clinical Science · doi:10.1042/cs20140012 · Cited by 53
Increased activation of the hypoxia-inducible factor pathway in varicose veins
Lim, C. S., Kiriakidis, S., Paleolog, E. M., & Davies, A. H. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.10.111 · Cited by 53
Wang, X., & Schneider, A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq078 · Cited by 56
The Ontogeny and Microenvironmental Regulation of Tumor-Associated Macrophages
Movahedi, K., & Ginderachter, J. A. V. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6704 · Cited by 53
From Erythropoietin to Oxygen: Hypoxia-Inducible Factor Hydroxylases and the Hypoxia Signal Pathway
Ratcliffe, P. J. (2002) · Blood Purification · doi:10.1159/000065201 · Cited by 53
Regulation of HMG‐CoA reductase expression by hypoxia
Pallottini, V., Guantario, B., Martini, C., Totta, P., Filippi, I., Carraro, F., & Trentalance, A. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21757 · Cited by 53
The Hypoxic Inducible Stress Response as a Target for Cancer Drug Discovery
Welsh, S. J., Koh, M. Y., & Powis, G. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.011 · Cited by 54
Wenger, R. H., & Kurtz, A. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100075 · Cited by 55
Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor Efficacy
Veliça, P., Cunha, P. P., Vojnovic, N., Foskolou, I. P., Bargiela, D., Gojkovic, M., Rundqvist, H., & Johnson, R. S. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0561 · Cited by 52
“The second oxygen-sensitive mechanism utilizes the factor-inhibiting HIF (FIH) enzyme, which hydroxylates a conserved asparagine residue in HIFa subunits, blocking association with the p300/CBP coactivator and thus HIF transcriptional activity (15, 16).”
BackgroundWollenick, K., Hu, J. J., Kristiansen, G., Schraml, P., Rehrauer, H., Berchner‐Pfannschmidt, U., Fandrey, J., Wenger, R. H., & Stiehl, D. P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr978 · Cited by 53
Ratcliffe, P. P., & Bishop, T. (2014) · Hypoxia · doi:10.2147/hp.s47598 · Cited by 55
Janke, K., Brockmeier, U., Kuhlmann, K., Eisenacher, M., Nolde, J., Meyer, H. E., Mairbäurl, H., & Metzen, E. (2013) · Journal of Cell Science · doi:10.1242/jcs.117564 · Cited by 53
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer
Paschalis, A., Welti, J. C., Neeb, A., Yuan, W., Figueiredo, I., Pereira, R., Ferreira, A., Riisnaes, R., Rodrigues, D. N., Jiménez‐Vacas, J. M., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1807 · Cited by 52
Mechanisms of O2 Activation by Mononuclear Non-Heme Iron Enzymes
Solomon, E. I., DeWeese, D. E., & Babicz, J. T. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00370 · Cited by 54
Gene transcription and chromatin regulation in hypoxia
Batie, M., & Rocha, S. (2020) · Biochemical Society Transactions · doi:10.1042/bst20191106 · Cited by 52
Vitamin C: From nutrition to oxygen sensing and epigenetics
Kietzmann, T. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102753 · Cited by 57
HDACi - going through the mechanisms
Wańczyk, M. (2010) · Frontiers in bioscience · doi:10.2741/3691 · Cited by 51
Identification of the angiogenic gene signature induced by EGF and hypoxia in colorectal cancer
Khong, T. L., Thairu, N., Larsen, H., Dawson, P. M., Kiriakidis, S., & Paleolog, E. M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-518 · Cited by 54
Hypoxia Signaling Regulates Macrophage Migration Inhibitory Factor (MIF) Expression in Stroke
Zis, O., Zhang, S., Dorovini‐Zis, K., Wang, L., & Song, W. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8727-4 · Cited by 52
Boeckel, J., Derlet, A., Glaser, S.-F., Luczak, A., Lucas, T., Heumüller, A. W., Krüger, M., Zehendner, C. M., Kaluza, D., Doddaballapur, A., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307695 · Cited by 51
Puduvalli, V. K., Wu, J., Yuan, Y., Armstrong, T. S., Vera, E., Xu, J., Xu, J., Giglio, P., Colman, H., Walbert, T., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa062 · Cited by 51
Identification and characterization of the hypoxia-responsive element in human stanniocalcin-1 gene
Law, A. Y. S., Ching, L. Y., Lai, K. P., & Wong, C. K. C. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.007 · Cited by 52
Haddad, J. J. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00022-0 · Cited by 51
Womeldorff, M. R., Gillespie, D. L., & Jensen, R. L. (2014) · Neurosurgical FOCUS · doi:10.3171/2014.9.focus14496 · Cited by 51
Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1
Hubbi, M. E., Gilkes, D. M., Baek, J. H., & Semenza, G. L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.278630 · Cited by 50
Self-citationHDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma
Ramakrishnan, S., Ku, S., Ciamporcero, E. S., Miles, K. M., Attwood, K. M., Chintala, S., Shen, L., Ellis, L., Sotomayor, P. C., Swetzig, W. M., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2604-7 · Cited by 50
The interplay between HIF-1 and calcium signalling in cancer
Azimi, I. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.02.001 · Cited by 54
Walmsley, S. R., McGovern, N. N., Whyte, M. K. B., & Chilvers, E. R. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0331tr · Cited by 52
Lee, Y.-M., Lim, J.-H., Chun, Y., Moon, H.-E., Lee, M. K., Huang, E. L., & Park, J. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp196 · Cited by 49
Martínez-Noël, G., Luck, K., Kühnle, S., Desbuleux, A., Szajner, P., Galligan, J. T., Rodriguez, D., Zheng, L., Boyland, K. A., Leclere, F., et al. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.021 · Cited by 53
Zhong, H., Willard, M. T., & Simons, J. W. (2004) · International Journal of Cancer · doi:10.1002/ijc.20438 · Cited by 49
Oxygen: Modulator of Physiological and Pathophysiological Processes in the Liver
Kietzmann, T., Dimova, E. Y., Flügel, D., & Scharf, J. (2006) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2005-858987 · Cited by 49
Tan, E. Y., Campo, L., Han, C., Turley, H., Pezzella, F., Gatter, K. C., Harris, A. L., & Fox, S. B. (2007) · Breast Cancer Research · doi:10.1186/bcr1838 · Cited by 51
Liu, Q., Möller, U., Flügel, D., & Kietzmann, T. (2004) · Blood · doi:10.1182/blood-2004-03-1017 · Cited by 49
Zhu, D., Wei, W., Zhang, J., Zhao, B., Li, Q., & Jin, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24656 · Cited by 48
Wang, E., Zhang, C., Polavaram, N. S., Liu, F., Wu, G., Schroeder, M. A., Lau, J. S., Mukhopadhyay, D., Jiang, S., O’Neill, B. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086102 · Cited by 49
Yoo, Y. H., Na, T.-Y., Yang, W.-K., Kim, H.-J., Lee, I.-K., Kong, G., Chung, J.-H., & Lee, M.-O. (2006) · Oncogene · doi:10.1038/sj.onc.1210149 · Cited by 49
Thiersch, M., Rimann, M., Panagiotopoulou, V., Öztürk, E., Biedermann, T., Textor, M., Lühmann, T. C., & Hall, H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.021 · Cited by 48
Chen, Z., Liu, X., Mei, Z., Wang, Z., & Xiao, W. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00718-13 · Cited by 48
Hypoxia-inducible factor-1alpha: A promising therapeutic target in endometriosis
Zhan, L., Wang, W., Zhang, Y., Song, E., Fan, Y., & Wei, B. (2016) · Biochimie · doi:10.1016/j.biochi.2016.01.006 · Cited by 48
Hirota, K. (2020) · Biomedicines · doi:10.3390/biomedicines8020032 · Cited by 52
Self-citationDayan, F., Monticelli, M., Pouysségur, J., & Pécou, E. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.03.009 · Cited by 48
Lombardi, O., Li, R., Halim, S., Choudhry, H., Ratcliffe, P. J., & Mole, D. R. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111652 · Cited by 48
Notch signaling, hypoxia, and cancer
Guo, M., Niu, Y., Xie, M., Liu, X., & Li, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1078768 · Cited by 48
He, W., & Kang, Y. J. (2012) · Cardiovascular Toxicology · doi:10.1007/s12012-012-9174-y · Cited by 48
Metabolic Checkpoints in Differentiation of Helper T Cells in Tissue Inflammation
Roy, S., Rizvi, Z. A., & Awasthi, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03036 · Cited by 50
Activation of hypoxia-induced transcription in normoxia
Hägg, M., & Wennström, S. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.01.017 · Cited by 47
Schweppe, R. E., Cheung, T. H., & Ahn, N. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604208200 · Cited by 49
Pulmonary Vascular Responses to Chronic Hypoxia Mediated by Hypoxia-inducible Factor 1
Semenza, G. L. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200404-029ms · Cited by 47
Self-citationHou, P., Kuo, C., Cheng, C.-T., Liou, J., Ann, D. K., & Chen, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113865 · Cited by 46
Miguel, M. P., Alcaina, Y., de la Maza, D. S., & López-Iglesias, P. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150505160406 · Cited by 47
Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease?
Strowitzki, M. J., Ritter, A. S., Kimmer, G., & Schneider, M. A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104364 · Cited by 47
Ocular versus Extraocular Neovascularization: Mirror Images or Vague Resemblances
Campochiaro, P. A. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1494 · Cited by 47
Feng, J., Zhang, Y., She, X., Sun, Y., Fan, L., Ren, X., Fu, H., Liu, C., Li, P., Zhao, C., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0423-9 · Cited by 47
Cai, X., Zhang, D., Wang, J., Liu, X., Ouyang, G., & Xiao, W. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003004 · Cited by 47
Hypoxia Pathway Proteins in Normal and Malignant Hematopoiesis
Wielockx, B., Grinenko, T., Mirtschink, P., & Chavakis, T. (2019) · Cells · doi:10.3390/cells8020155 · Cited by 51
Sadaghianloo, N., Contenti, J., Dardik, A., & Mazure, N. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215387 · Cited by 45
HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1α/lncRNA BACE1-AS axis
Sil, S., Hu, G., Liao, K., Niu, F., Callen, S. E., Periyasamy, P., Fox, H. S., & Buch, S. J. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000660 · Cited by 46
Matsumoto, K., Imagawa, S., Obara, N., Suzuki, N., Takahashi, S., Nagasawa, T., & Yamamoto, M. P. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20733 · Cited by 46
Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1α
Peng, Z.-G., Zhou, M. Y., Huang, Y., Qiu, J., Wang, L., Liao, S. H., Dong, S., & Chen, G. (2007) · Oncogene · doi:10.1038/sj.onc.1210676 · Cited by 46
SM-20, EGL-9, and the EGLN Family of Hypoxia-inducible Factor Prolyl Hydroxylases
Freeman, R. S., Hasbani, D. M., Lipscomb, E. A., Straub, J. A., & Xie, L. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13758-7 · Cited by 45
Hypoxia-Inducible Factor 1-Related Diseases and Prospective Therapeutic Tools
Park, J., Chun, Y., & Kim, M. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.94.221 · Cited by 45
Wu, Y., Li, Z., McDonough, M. A., Schofield, C. J., & Zhang, X. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00415 · Cited by 45
Yadu, N., Singh, M. R., Singh, D., & Keshavkant, S. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125117 · Cited by 44
Role of HIF1 α Regulatory Factors in Stem Cells
Lee, H. J., Jung, Y. H., Choi, G. E., Kim, J. S., Chae, C. W., & Han, H. J. (2019) · International Journal of Stem Cells · doi:10.15283/ijsc18109 · Cited by 45
The von Hippel‐Lindau Tumor Suppressor Protein: An Update
Kaelin, W. G. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35019-2 · Cited by 45
IOP1, a novel hydrogenase-like protein that modulates hypoxia-inducible factor-1α activity
Huang, J., Song, D., Flores, A. G., Zhao, Q., Mooney, S. M., Shaw, L. M., & Lee, F. S. (2006) · Biochemical Journal · doi:10.1042/bj20060635 · Cited by 45
Rawłuszko-Wieczorek, A. A., Bujnicka, K. E., Horbacka, K., Krokowicz, P., & Jagodziński, P. P. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-526 · Cited by 44
Hampton‐Smith, R. J., & Peet, D. J. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05035.x · Cited by 45
The Role of the Hypoxia-Related Unfolded Protein Response (UPR) in the Tumor Microenvironment
Bartoszewska, S., Collawn, J. F., & Bartoszewski, R. (2022) · Cancers · doi:10.3390/cancers14194870 · Cited by 43
Zakharia, Y., Bhattacharya, A., & Rustum, Y. M. (2018) · Oncotarget · doi:10.18632/oncotarget.24297 · Cited by 43
Tumor-derived extracellular vesicles in angiogenesis
Song, W., Yan, D., Wei, T., Liu, Q., Zhou, X., & Liu, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.148 · Cited by 43
Hypoxia Regulates BMP4 Expression in the Murine Spleen during the Recovery from Acute Anemia
Wu, D.-C., & Paulson, R. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011303 · Cited by 43
Mitochondria and Hypoxia‐induced Gene Expression Mediated by Hypoxia‐inducible Factors
Chavez, A., Miranda, L. F., Pichiule, P., & Chavez, J. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.021 · Cited by 43
The Asparagine Hydroxylase FIH: A Unique Oxygen Sensor
Volkova, Y. L., Pickel, C., Jucht, A. E., Wenger, R. H., & Scholz, C. C. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0003 · Cited by 43
Searching for molecular hypoxia sensors among oxygen-dependent enzymes
Li, L., Shen, S. Q., Bickler, P. E., Jacobson, M. P., Wu, L. F., & Altschuler, S. J. (2023) · eLife · doi:10.7554/elife.87705 · Cited by 43
Involvement of HIF-1α in MLCK-dependent Endothelial Barrier Dysfunction in Hypoxia
Qi, H., Wang, P., Liu, C., Li, M., Wang, S., Huang, Y., & Wang, F. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000327951 · Cited by 42
Metabolic Implications of Circadian–HIF Crosstalk
Peek, C. B. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.02.008 · Cited by 44
Metadata
- Authors
- Mahon, P. C., Hirota, K., & Semenza, G. L.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2001-10-15
- Volume
- 15
- Issue
- 20
- Pages
- 2675-2686
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC312814
- OpenAlex
- W2089692551
- Semantic Scholar
- 76cac1c7209112ecf9989f7cc81e563b7881292c
- Cited by
- 1,385
- References
- 47
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 40 · 2023: 52 · 2022: 63 · 2021: 71 · 2020: 58 · 2019: 64 · 2018: 47 · 2017: 50 · 2016: 61 · 2015: 60 · 2014: 54 · 2013: 56 · 2012: 59
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Uehara Memorial Foundation
- National Institutes of Health (5r01dk039869-16)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK39869)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- FIH-1, HIF-1α, VHL, HIF-1, transcriptional repression, histone deacetylase, corepressors, oxygen sensing, protein-protein interaction, ubiquitination, proteasomal degradation, oxygen homeostasis
- MeSH terms
- Amino Acid Sequence, Animals, Cells, Cultured, DNA-Binding Proteins, Fungal Proteins, Gene Expression Regulation, Glutathione Transferase, Histone Deacetylases, Humans, Mixed Function Oxygenases, Ligases, Luciferases, Molecular Sequence Data, Nuclear Proteins, Oxygen, Protein Conformation, Rabbits, Repressor Proteins, Reticulocytes, Saccharomyces cerevisiae, Transcription Factors, Transcription, Genetic, Signal Transduction, Transcriptional Activation, Cell Hypoxia, Polymerase Chain Reaction, Sequence Homology, Amino Acid, DNA Primers, Two-Hybrid System Techniques, Tumor Suppressor Proteins, Saccharomyces cerevisiae Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
